Some Interesting Pharmaceutical Industry Fun FactsPrometic will soon be chasing a US$58+ billion dollar WW market with their two drugs, Ryplazim and 4050, and has a chance to take its place among the industry leaders.
Ryplazim has no current competition and will own the plasminogen WW market. I know of no other pharmaceutical company currently pursuing the plasminogen market.
4050 has the chance to become the market’s standard/drug of choice as the only currently know drug to reverse fibrosis in five organs.
Below are listed the revenue for some of the largest pharmaceuticals (2016 data):
- Johnson & Johnson: US$71.89 billion
- Pfizer: US$52.82 billion
- Roche: US$50.11 billion
- Novartis: US$48.52 billion
- Merck & Co: US$39.8 billion
- Sanofi: US$36.57 billion
- GlaxoSmithKline (GSK): US$34.79 billion
- Gilead: US$30.39 billion
How big of a slice of the US$58+ billion WW market will Prometic be able to capture? Only time will tell. But 2020 appears to be when it may finally all come together for Prometic.